Trabectedin Maintenance Post 1st-line in STS .This study is not yet open for participant recruitment.
Verified October 2016 by European Organisation for Research and Treatment of Cancer - EORTC .
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC .
Collaborator:
PharmaMar .
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC
Maintenance therapy with trabectedin versus observation after first line treatment with doxorubicin of patients with advanced or metastatic soft tissue sarcoma.
This is a prospective, multicenter, randomized, open label Phase III trial investigating whether a maintenance treatment with trabectedin, as compared to the observational approach, can prolong progression-free survival in patients with advanced, inoperable and/or metastatic STS after response or stabilisation during first line treatment with doxorubicin.
Locations :
| Netherlands | |
| Leiden University Medical Center | Not yet recruiting |
| Leiden, Netherlands | |